Craniopharyngioma.
Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S.
Nat Rev Dis Primers. 2019 Nov 7;5(1):75. doi: 10.1038/s41572-019-0125-9.
Craniopharyngioma with malignant transformation: Review of literature.
Narla S, Govindraj J, Chandrasekar K, Sushama P.
Neurol India. 2017 Mar-Apr;65(2):418-420. doi: 10.4103/neuroindia.NI_528_16.
Current Approaches to Craniopharyngioma Management.
Diaz MJ, Kwak SH, Root KT, Fadil A, Nguyen A, Ladehoff L, Batchu S, Lucke-Wold B.
Front Biosci (Landmark Ed). 2022 Dec 21;27(12):328. doi: 10.31083/j.fbl2712328.
Histopathological features of malignant craniopharyngioma: Case report and literature review.
Mezmezian MB, Fernandez Ugazio G, Paparella ML.
Clin Neuropathol. 2020 Jan/Feb;39(1):25-31. doi: 10.5414/NP301189.
Malignant craniopharyngioma.
Kristopaitis T, Thomas C, Petruzzelli GJ, Lee JM.
Arch Pathol Lab Med. 2000 Sep;124(9):1356-60. doi: 10.5858/2000-124-1356-MC.
Malignant Craniopharyngioma: A Report of Seven Cases and Review of the Literature.
Wang F, He Y, Li C, Wang Y, Zhong L.
World Neurosurg. 2020 Mar;135:e194-e201. doi: 10.1016/j.wneu.2019.11.111. Epub 2019 Nov 27.
National UK guidelines for the management of paediatric craniopharyngioma.
Gan HW, Morillon P, Albanese A, Aquilina K, Chandler C, Chang YC, Drimtzias E, Farndon S, Jacques TS, Korbonits M, Kuczynski A, Limond J, Robinson L, Simmons I, Thomas N, Thomas S, Thorp N, Vargha-Khadem F, Warren D, Zebian B, Mallucci C, Spoudeas HA.
Lancet Diabetes Endocrinol. 2023 Sep;11(9):694-706. doi: 10.1016/S2213-8587(23)00162-6. Epub 2023 Aug 4.
Craniopharyngioma.
Müller HL.
Endocr Rev. 2014 Jun;35(3):513-43. doi: 10.1210/er.2013-1115. Epub 2014 Jan 27.
Childhood-onset Craniopharyngioma.
Otte A, Müller HL.
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3820-e3836. doi: 10.1210/clinem/dgab397.
Malignant transformation of craniopharyngioma: case report and review of the literature.
Gao S, Shi X, Wang Y, Qian H, Liu C.
J Neurooncol. 2011 Jul;103(3):719-25. doi: 10.1007/s11060-010-0407-2. Epub 2010 Sep 26.
